Life sciences companies can look to the automotive industry for ideas about collaborating with patients to co-create new ...

By sharing early-stage tools and data openly, life sciences companies can minimize duplication and de-risk R&D without ...

On this weeks Business of Biotech, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean drug development company to address an unmet ...

A key focus of Part III in this clinical trial payment series is the tax implications of trial payments. This article emphasizes that while reimbursements for out-of-pocket expenses are tax-exempt and ...

More than half of drug launches fall short of forecasts. Engaging payers during trial design and capturing outcomes with real ...

What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and ...

Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent court ruling, however, adds new complexity, write experts at Finnegan.

<p>On this week&#39;s episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, ...

A client in Ireland acquired an aseptic operations facility with plans to expand into GMP microbiology laboratory services, despite having previously outsourced all microbiology work and lacking ...

A client in the Southeastern U.S. faced challenges meeting project timelines due to restrictions on increasing headcount and reliance on temporary employees, which negatively affected team morale.